| 41 | 0 | 36 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 基于倾向性评分匹配(PSM)分析入院中性粒细胞百分比与白蛋白比值(NPAR)对扩张型心肌病(DCM)致心力衰竭(HF)患者不良预后的预测价值。方法 回顾性选取2022年1月—2024年6月收治的DCM致HF患者220例。收集患者入院后相关临床资料,使用自动化血细胞分析仪检测中性粒细胞百分比,采用溴甲酚绿法检测白蛋白水平,计算两者比值(即NPAR)。随访1年,随访期内患者发生再次HF入院、恶性心律失常、心源性死亡或全因死亡事件定义为不良预后。采用PSM对不同预后DCM导致HF患者进行1∶1匹配,得到组间变量均衡样本。采用多因素Logistic回归分析影响DCM致HF患者不良预后的独立危险因素,并通过受试者工作特征(ROC)曲线评估各危险因素对患者不良预后的预测价值。结果 220例中82例患者预后不良,发生率为37.3%。PSM匹配后共得到78对基线特征均衡的患者样本。PSM后不良预后患者较良好预后者左心室射血分数、白蛋白低,中性粒细胞百分比、N末端前体B型钠尿肽(NT-proBNP)、肌钙蛋白I、C反应蛋白和NPAR高(P均<0.05)。多因素Logistic回归分析显示,NT-proBNP高和NPAR高为DCM致HF患者不良预后的独立危险因素(P均<0.05)。ROC曲线分析显示,NPAR预测DCM致HF患者不良预后的AUC为0.781,高于中性粒细胞百分比、白蛋白单独预测的0.699、0.716(P均<0.05);NT-proBNP与NPAR联合预测不良预后的AUC为0.850,高于NT-proBNP、NPAR单独预测的0.746、0.781(P均<0.05)。结论 入院NPAR较高为DCM致HF患者不良预后的独立危险因素,对患者预后有一定的预测价值,且联合NT-proBNP后预测价值可进一步提高。
Abstract:Objective To analyze the predictive value of the admission neutrophil-percentage-to-albumin ratio(NPAR) for poor prognosis in patients with heart failure(HF) due to dilated cardiomyopathy(DCM) based on propensity score matching(PSM). Methods A total of 220 patients with HF due to DCM admitted from January 2022 to June 2024 were retrospectively selected. Relevant clinical data were collected upon admission. Neutrophil percentage was measured using an automated hematology analyzer, and albumin levels were determined using the bromocresol green method, with NPAR calculated as their ratio. During the one-year follow-up, poor prognosis was defined as the occurrence of rehospitalization for HF, malignant arrhythmia, cardiac death, or all-cause death. A 1:1 PSM was applied to patients with different prognoses to obtain a sample with balanced intergroup variables. Multivariate Logistic regression analysis was used to identify independent risk factors for poor prognosis in patients with HF due to DCM. The predictive values of N-terminal pro-Btype natriuretic peptide(NT-proBNP) and NPAR for poor prognosis were assessed using receiver operating characteristic(ROC) curve. Results Among 220 patients, 82 patients experienced poor prognosis, with an incidence of 37. 3%. After PSM, 78 matched pairs of patients with balanced baseline characteristics were obtained. Following PSM, patients with poor prognosis showed significantly lower left ventricular ejection fraction and albumin levels, and significantly higher neutrophil percentage, NT-proBNP, troponin I, C-reactive protein, and NPAR than patients with good prognosis(all P<0. 05). Multivariate Logistic regression analysis revealed that elevated NT-proBNP and elevated NPAR were independent risk factors for poor prognosis in patients with HF due to DCM(all P<0. 05). ROC curve analysis demonstrated that the area under the curve(AUC) of NPAR in predicting poor prognosis was 0. 781, which was higher than the AUCs of neutrophil percentage(0. 699) and albumin(0. 716) alone(both P<0. 05). The combined prediction of NT-proBNP and NPAR achieved an AUC of 0. 850, which was higher than the AUCs of NT-proBNP(0. 746) or NPAR(0. 781) alone(both P < 0. 05). Conclusions Elevated admission NPAR is an independent risk factor for poor prognosis in patients with HF due to DCM and holds predictive value for patient prognosis. Furthermore, combining NPAR with NT-proBNP further enhances the predictive value for poor prognosis in these patients.
[1]国家心血管病中心,中国心血管健康与疾病报告编写组.中国心血管健康与疾病2023概要[J].中国循环杂志,2024,39(7):625-660.
[2]WANG H, LI Y Y, CHAI K, et al. Mortality in patients admitted to hospital with heart failure in China:a nationwide cardiovascular association database-heart failure centre registry cohort study[J]. Lancet Glob Health, 2024,12(4):611-622.
[3]心血管健康联盟,中国老年医学学会心电与心功能分会,心衰中心联盟专家委员会.中国心衰中心联盟心力衰竭医疗质量报告(2022年)[J].中华全科医师杂志,2023,22(6):557-568.
[4]中国医师协会心力衰竭专业委员会,国家心血管病专家委员会心力衰竭专业委员会,中华心力衰竭和心肌病杂志编辑委员会.心力衰竭生物标志物临床应用中国专家共识[J].中华心力衰竭和心肌病杂志,2022,06(3):175-192.
[5]WANG R, TAO W J, CHEN H L, et al. Investigating nonlinear associations between neutrophil percentage to albumin ratio and cardiovascular disease:a nationally representative cross-sectional study[J]. Sci Rep, 2024,14(1):23632.
[6]赵江峰,畅晓燕,安明春,等.中性粒细胞百分比与白蛋白比值对慢性心力衰竭急性加重患者30天死亡的预后价值[J].心肺血管病杂志,2022,41(12):1216-1220.
[7]周松,郝清卿,黄玲芳,等.血清补体C1q/肿瘤坏死因子相关蛋白3、波形蛋白水平与扩张型心肌病慢性心力衰竭患者预后的关系[J].中国医药导报,2024,21(17):54-57.
[8]高妍芬,葛青,邹鹏,等.血清ATX、TN-C与老年扩张型心肌病合并心力衰竭患者心室重构指标的相关性及对预后的影响[J].国际检验医学杂志2024,45(15):1816-1821.
[9]中华医学会心血管病学分会,中国心肌炎心肌病协作组.中国扩张型心肌病诊断和治疗指南[J].临床心血管病杂志,2018,34(5):421-434.
[10]中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789.
[11]HEYMANS S, LAKDAWALA N K, TSCHÖPE C, et al. Dilated cardiomyopathy:causes, mechanisms, and current and future treatment approaches[J]. Lancet, 2023,402(10406):998-1011.
[12]中华医学会心血管病学分会,中国医师协会心血管内科医师分会,中国医师协会心力衰竭专业委员会,等.中国心力衰竭诊断和治疗指南2024[J].中华心血管病杂志,2024,52(3):235-275.
[13]LIAU M Y Q, TOH E Q, MUHAMED S, et al. Can propensity score matching replace randomized controlled trials[J]. World J Methodol, 2024,14(1):90590.
[14]CSCO生物统计学专家委员会RWS方法学组.倾向性评分方法及其规范化应用的统计学共识[J].中国卫生统计,2020,37(6):952-958.
[15]BOULET J, SRIDHAR V S, BOUABDALLAOUI N, et al. Inflammation in heart failure:pathophysiology and therapeutic strategies[J]. Inflamm Res,2024,73(5):709-723.
[16]AROCA-CREVILLÉN A, VICANOLO T, OVADIA S, et al.Neutrophils in physiology and pathology[J]. Annu Rev Pathol,2024,1(19):227-259.
[17]WANG Y M, SHOU X T, WU Y, et al. Immuno-inflammatory pathogenesis in ischemic heart disease:perception and knowledge for neutrophil recruitment[J]. Front Immunol, 2024,7(15):1411301.
[18]ZHANG Y Y, FENG L, ZHU Z X, et al. Association between blood inflammatory indices and heart failure:a cross-sectional study of NHANES 2009-2018[J]. Acta Cardiol, 2024,79(4):473-485.
[19]WU N J, LIU T T, TIAN M M, et al. Albumin, an interesting and functionally diverse protein, varies from‘native’ to‘effective’(review)[J]. Mol Med Rep, 2024,29(2):24.
[20]赵镜淋,王莉莉,郭妮娜.血清白蛋白水平与心力衰竭的关系[J].中国心血管病研究,2022,20(6):491-496.
[21]WAN X, GU L, LIU H G, et al. Correlation between blood albumin and hospital death and long-term death in ICU patients with heart failure:data from the medical information mart for intensive careⅢdatabase[J]. Am J Cardiovasc Dis, 2024,14(1):29-39.
[22]FU H, FENG W X. The predictive value of NPAR combined with WBCHR for adverse cardiovascular events after acute ST-segment elevation myocardial infarction[J]. Minerva Med, 2024,6(19):1-10.
[23]LIU Y T, QIU Z F, SHEN G, et al. Associations between neutrophil-percentage-to-albumin ratio level and all-cause mortality and cardiovascular disease-cause mortality in general population:evidence from NHANES 1999-2010[J]. Front Cardiovasc Med,2024,9(11):1393513.
[24]王欣,张媛,徐晓蓉,等.入院中性粒细胞百分比/白蛋白比值与不同类型慢性心力衰竭患者临床预后的相关性分析[J].中国心血管杂志,2024,29(5):412-418.
[25]WANG X, ZHANG Y, WANG Y X, et al. The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with chronic heart failure[J]. BMC Cardiovasc Disord,2023,23(1):568.
[26]中国医师协会检验医师分会心血管专家委员会. B型利钠肽及N末端B型利钠肽前体实验室检测与临床应用中国专家共识[J].中华医学杂志,2022,102(35):2738-2754.
基本信息:
中图分类号:R542.2;R541.6
引用信息:
[1]翟建涛,刘青,席雅曼,等.基于倾向性评分匹配分析入院NPAR对扩张型心肌病致心力衰竭患者预后不良的预测价值[J].山东医药,2026,66(01):12-17.
基金信息:
天津市卫生健康科技项目(TJWJ2023MS066)